Mabpharm (HKSE:02181) Other Operating Expense : HK$87.91 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Mabpharm Other Operating Expense?

Mabpharm's Other Operating Expense for the six months ended in Dec. 2023 was HK$50.84 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$87.91 Mil.

Mabpharm's quarterly Other Operating Expense increased from Dec. 2022 (HK$17.47 Mil) to Jun. 2023 (HK$37.07 Mil) and increased from Jun. 2023 (HK$37.07 Mil) to Dec. 2023 (HK$50.84 Mil).

Mabpharm's annual Other Operating Expense declined from Dec. 2021 (HK$69.15 Mil) to Dec. 2022 (HK$46.53 Mil) but then increased from Dec. 2022 (HK$46.53 Mil) to Dec. 2023 (HK$87.91 Mil).

Mabpharm Other Operating Expense Historical Data

The historical data trend for Mabpharm's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabpharm Other Operating Expense Chart

Mabpharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

38.66

28.99

69.15

46.53

87.91

Mabpharm Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial								31.09	30.50	17.47	37.07	50.84

Mabpharm Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$87.91 Mil.

Mabpharm Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Mabpharm's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mabpharm (HKSE:02181) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabpharm Ltd (HKSE:02181) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lujia Road East, Koutai Road West, Block G79, China Medical City, Taizhou, CHN, 225300

Website

http://www.mabpharm.cn

Mabpharm Ltd is a biopharmaceutical company. The company is engaged in the research, development, and production of new drugs and biosimilars for cancers and autoimmune diseases. Its core products include CMAB008 (infliximab), CMAB007 (omalizumab), and CMAB009 (cetuximab).

Executives

Guo Jianjun	2307 Founder of a discretionary trust who can infl
Asia Mabtech Limited
Asia Pacific Immunotech Venture Limited
Guo Family (ptc) Limited
Fortune-healthy Investment Limited
Link Best Capital Limited
Cdh Fund V, L.p.
Cdh Mabtech Limited
Cdh V Holdings Company Limited
China Diamond Holdings Company Limited
China Diamond Holdings V Limited

Mabpharm (HKSE:02181) Headlines

No Headlines